This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Stock, C. C., Amer. J. Med., 8, 658 (1950); Reilly, H. C., Stock, C. C., Buckley, S. M., and Clarke, D. A., Cancer Res., 13, 684 (1953).
Ehrlich, J., Anderson, L. E., Coffey, G. L., Hillegas, A. B., Knudsen, M. P., Koepsell, H. J., Kohberger, D. L., and Oyaas, J. E., Nature (see following communication).
Bartz, Q. R., Elder, C. C., Frohardt, R. P., Fusari, S. A., Haskell, T. H., Johannessen, D. W., and Ryder, A., Nature (see following communication).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
STOCK, C., REILLY, H., BUCKLEY, S. et al. Azaserine, A New Tumour-Inhibitory Substance: Studies with Crocker Mouse Sarcoma 180. Nature 173, 71–72 (1954). https://doi.org/10.1038/173071a0
Issue date:
DOI: https://doi.org/10.1038/173071a0
This article is cited by
-
Complete integration of carbene-transfer chemistry into biosynthesis
Nature (2023)
-
Targeting mitochondrial metabolism for precision medicine in cancer
Cell Death & Differentiation (2022)
-
Teratogenic effects of azaserine in the Syrian golden hamster
Experientia (1983)
-
Biogenetic amino acid antagonists
Die Naturwissenschaften (1971)
